Paysign Inc. Reports Significant Increase in Sales and Net Income for Fiscal Period, EPS Exceeds Expectations

Reuters
2025/06/04
<a href="https://laohu8.com/S/PAYS">Paysign Inc</a>. Reports Significant Increase in Sales and Net Income for Fiscal Period, EPS Exceeds Expectations

Paysign Inc., a leading provider of prepaid card programs and payment processing solutions, has released its financial results. The company reported a variation in Adjusted EBITDA, a non-GAAP measure, which excludes stock-based compensation charges. Paysign emphasizes that EBITDA and Adjusted EBITDA are not indicators of cash flows from operations or net income as defined by U.S. GAAP. The financial results also highlight the company's commitment to technology advancements aimed at reducing administrative costs, streamlining operations, and driving revenue for its customers. No specific figures regarding sales/revenues, net income/profit/loss, or earnings per share $(EPS)$ were disclosed in the document. The company also provides customized, scalable solutions with a strong focus on the healthcare industry. Paysign is headquartered in southern Nevada and has been in operation for over 20 years, partnering with major pharmaceutical and healthcare companies as well as multinational corporations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Paysign Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10